According to news on September 10, China Chemical (601117) once fell to the limit during the session and is currently trading at 13.58 yuan. Unlike yesterday's daily limit, which hit a record high in stock prices, the upward trend did not continue today. According to public data,

is different from the record high stock price hit by the daily limit yesterday, and it did not continue its upward trend today.

According to public data, in the first half of 2021, China Chemical achieved revenue of 55.915 billion yuan, +53.08% year-on-year; net profit attributable to the parent company was 1.932 billion yuan, +33.7% year-on-year.

Guotai Junan released a research report stating that China Chemical's tens of billions of fixed growth will accelerate its transformation into "technology + industry" and its core competitiveness will be its R&D strength. The State-owned Assets Supervision and Administration Commission requires central enterprises to strengthen research on key technologies such as new materials, create a "source of original technology", and shoulder the responsibility of "chain owner" of the industrial chain. The company's domestic coal chemical industry 90%/basic chemical industry 90%/petrochemical industry 60% share leads the industry.

The conditions for China's chemical transformation are the long-term strategy of industrial development/optimization of top-level design and R&D platforms/sustained high-intensity R&D investment and incentive mechanism construction/accelerated implementation of substantive R&D results, etc. In the past three years, it has invested nearly 10 billion in R&D, and its R&D rate of 3.5% is higher than Wanhua Chemical's 2.8%. The tens of billions of private placements were completed, with 1.176 billion shares issued at 8.5 yuan per share, raising a net amount of 9.967 billion. The controlling shareholder subscribes for 30%.